 |
|
Knowledge of HIV Antibody Status and Decisions to Continue or Terminate Pregnancy Among Intravenous Drug Users
Peter A. Selwyn, MD, MPH;
Rosalind J. Carter;
Ellie E. Schoenbaum, MD;
Verna J. Robertson, FNP;
Robert S. Klein, MD;
Martha F. Rogers, MD
JAMA. 1989;261(24):3567-3571.
Abstract
| |
We studied decisions to continue or terminate pregnancy among human immunodeficiency virus (HIV)-seropositive ( + ) and -seronegative (-) intravenous drug users informed of HIV antibody status before 24 weeks' gestation. Fourteen (50%) of 28 HIV+ vs 16 (44%) of 36 HIV- women chose to terminate their pregnancies. In retrospective interviews, HIV + women were more likely to have perceived their risk of perinatal HIV transmission to be greater than or equal to 50% and, among those who terminated pregnancy, to cite this concern as an important factor in their decision. However, decisions to terminate pregnancy were predicted more readily by pregnancy-related variables such as prior elective abortion, a negative emotional reaction to pregnancy, and whether the pregnancy had been unplanned. Women who were HIV + and chose to continue their pregnancies cited the desire for a child, religious beliefs, and family pressure as the most important factors in their decisions. Results indicate that while concerns about perinatal transmission of HIV may lead to decisions to terminate pregnancy in certain cases, there may be other determinants of pregnancy decisions in this population. Counseling of HIV-infected women must address not only perinatal transmission but also the sociocultural and behavioral context in which pregnancy decision making takes place.
(JAMA. 1989;261:3567-3571)
Author Affiliations
From the Departments of Epidemiology and Social Medicine (Drs Selwyn, Schoenbaum, and Klein, Ms Robertson, and Ms Carter) and Medicine, Division of Infectious Diseases (Drs Schoenbaum and Klein), Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY; and the Center for Infectious Diseases, Centers for Disease Control, Atlanta, Ga (Dr Rogers).
Footnotes
Reprint requests to Montefiore Medical Center, 110 E 210th St, Bronx, NY 10467 (Dr Selwyn).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Is natural conception a valid option for HIV-serodiscordant couples?
Barreiro et al.
Hum Reprod 2007;22:2353-2358.
ABSTRACT
| FULL TEXT
Prenatal Screening for HIV: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou et al.
ANN INTERN MED 2005;143:38-54.
ABSTRACT
| FULL TEXT
A Holistic Life View of Human Immunodeficiency Virus-Infected African American Women
Russell and Smith
J Holist Nurs 1999;17:331-345.
ABSTRACT
Decisions to Have a Baby by HIV-Infected Women
Sowell and Misener
West J Nurs Res 1997;19:56-70.
ABSTRACT
Economic Impact of Treatment of HIV-Positive Pregnant Women and Their Newborns With Zidovudine: Implications for HIV Screening
Mauskopf et al.
JAMA 1996;276:132-138.
ABSTRACT
Limited Effects of HIV Counseling and Testing for Women: A Prospective Study of Behavioral and Psychological Consequences
Ickovics et al.
JAMA 1994;272:443-448.
ABSTRACT
Preventive Services Guidelines for Primary Care Clinicians Caring for Adults and Adolescents Infected With the Human Immunodeficiency Virus
Gerber et al.
Arch Fam Med 1993;2:969-979.
ABSTRACT
AIDS-Related Risk Behavior, Knowledge, and Beliefs Among Women and Their Mexican-American Sexual Partners Who Used Intravenous Drugs
Parra et al.
Arch Fam Med 1993;2:603-610.
ABSTRACT
Screening Women of Childbearing Age for Human Immunodeficiency Virus: A Cost-benefit Analysis
Brandeau et al.
Arch Intern Med 1992;152:2229-2237.
ABSTRACT
Evidence for the Effects of HIV Antibody Counseling and Testing on Risk Behaviors
Higgins et al.
JAMA 1991;266:2419-2429.
ABSTRACT
Women Addicts and the Threat of AIDS
Suffet and Lifshitz
Qual Health Res 1991;1:51-79.
ABSTRACT
|
